Anthropic CEO predicts cancer, Alzheimer's will be 'relics of the past' within a decade

Anthropic CEO Dario Amodei has signaled the arrival of an AI-driven singularity as the company prepares for its initial public offering.

Amodei predicted that with AI's help, humanity could defeat cancer and Alzheimer's disease within a decade.

According to Business Insider, Amodei made the bold forecast in an IPO investor presentation video released Tuesday (local time), Yonhap reported.

"Cancer, Alzheimer's, heart disease and mental illness will be relics of the past within 10 years," he said.

Anthropic has been expanding into drug development by acquiring several biotech startups. In a blog post last October, the company said it had "begun its own drug discovery efforts."

In August, Amodei wrote on X that the best way to convince AI skeptics was for AI companies to "actually cure cancer." However, he added that "saying AI will cure cancer is closer to cliché than inspiration, and most people find it deceptive."

Meanwhile, Anthropic's IPO has drawn investor demand several times the size of the shares on offer.

Bloomberg reported Wednesday (local time), citing multiple sources familiar with the matter, that buy orders for Anthropic's IPO have come in at a multiple of the shares available for sale.

Demand has been driven particularly by major institutional investors seeking to acquire large allocations.

Anthropic launched its official roadshow on Tuesday, conducting a book-building process targeting institutional investors.

The level of demand confirmed through the process could influence the final offering price.

Anthropic has set a target price range of $70 to $78 per share. The total offering, combining new and existing shares, amounts to 825 million shares.

The combined value of Anthropic's new share offering, a separate private placement and existing shareholders' share sales could reach up to $90.4 billion. That would surpass the $85.7 billion SpaceX raised through its IPO in June and potentially make it the largest listing deal on record.